ARKGvsHELXETF Comparison
VS
ARK Genomic Revolution ETF (ARKG) and Franklin Genomic Advancements ETF (HELX) belong to the same industry segment: BioTech & Genomics. ARKG's top 1 sector exposures are Healthcare. In contrast, HELX's top sector exposures are Healthcare, Non-Energy Materials and Technology. ARKG is more expensive with a Total Expense Ratio (TER) of 0.75%, versus 0.5% for HELX. ARKG is up 76.72% year-to-date (YTD) with +$90M in YTD flows. HELX performs worse with 22.14% YTD performance, and +$8M in YTD flows. Run a side-by-side ETF comparison of ARKG and HELX below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
ARKG vs HELX performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 10/27/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | ARKG HELX | -3.25%-0.14% | +36.71%+14.08% | +76.72%+22.14% | +65.56%+28.70% | +132.21%+73.74% | -29.90%-14.82% |
| Flows | ARKG HELX | +$37M+$2M | +$51M+$2M | +$90M+$8M | +$63M+$8M | -$431M+$17M | -$2.01B+$8M |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | ARKG HELX | +49.99%+27.09% | +44.59%+23.97% | +44.73%+21.89% | +46.89%+23.66% |
| Max drawdown | ARKG HELX | -17.81%-8.93% | -27.52%-17.89% | -46.41%-29.16% | -76.56%-55.27% |
| Max drawdown duration | ARKG HELX | 22d22d | 126d206d | 882d458d | 1818d1820d |
Trading data
ARKG | HELX | |
Last sale 10/28/2026 at 1:30 PM | $54.82 | $45.47 |
| Previous close 10/27/2026 | $51.65 | $44.31 |
| Consolidated volume 10/27/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Advertisement
Main metrics
Last update 10/28/2026 at 1:30 PM
Live
Closed
ARKG | HELX | |
|---|---|---|
| Last price | $54.82 | $45.47 |
| 1D performance | +6.14% | +2.63% |
| AuM | $2.18 B | $35.46 M |
| E/R | 0.75% | 0.5% |
Characteristics
ARKG | HELX | |
|---|---|---|
| Management strategy | Active | Active |
| Provider | Ark Investment | Franklin Templeton |
| Benchmark | - | - |
| N° of holdings | 31 | 66 |
| Asset class | - | - |
| Trailing 12m distribution yield | Join | Join |
| Inception date | April 2, 2019 | February 25, 2020 |
| ESG | No | No |
Advertisement
Exposure
Countries
ARKG
USA
88.62%
Other
11.38%
HELX
USA
89.58%
Other
10.42%
Sectors
ARKG
Healthcare
97.89%
Other
2.11%
HELX
Healthcare
96.71%
Other
3.29%
Advertisement
Diversification
ARKG
Total weight of top 15 holdings out of 15
74.64%
HELX
Total weight of top 15 holdings out of 15
60.55%
Top 15 holdings
Data as of August 31, 2026
ARKG
10X Genomics, Inc.
9.58%
Twist Bioscience Corp.
9.13%
Tempus AI, Inc.
7.91%
CRISPR Therapeutics AG
6.10%
Personalis, Inc.
5.93%
Absci Corp.
4.88%
Natera, Inc.
4.06%
Illumina, Inc.
4.04%
Eli Lilly & Co.
3.86%
CareDx, Inc.
3.85%
Guardant Health, Inc.
3.81%
Beam Therapeutics, Inc.
3.56%
Compass Pathways Plc
3.17%
Recursion Pharmaceuticals, Inc.
2.44%
Adaptive Biotechnologies Corp.
2.32%
HELX
Guardant Health, Inc.
9.55%
Natera, Inc.
8.57%
Krystal Biotech, Inc.
5.64%
Adaptive Biotechnologies Corp.
4.49%
Ligand Pharmaceuticals, Inc.
4.22%
Twist Bioscience Corp.
4.19%
BridgeBio Pharma, Inc.
3.44%
United Therapeutics Corp.
3.08%
Travere Therapeutics, Inc.
2.99%
Vertex Pharmaceuticals, Inc.
2.78%
Medpace Holdings, Inc.
2.69%
Corteva, Inc.
2.50%
Eli Lilly & Co.
2.31%
Regeneron Pharmaceuticals, Inc.
2.15%
Repligen Corp.
1.97%
Frequently asked questions about ARKG and HELX
How have the ARKG and HELX ETFs performed in 2026?
As of October 27, 2026, ARKG is up 76.72% year-to-date (YTD), while HELX has returned 22.14%. That puts ARKG better performer ahead so far this year.
Which ETF is attracting more investor money: ARKG or HELX?
Year-to-date, the ARKG ETF saw +$90M in flows, compared to +$8M for HELX.
Which ETF is more volatile: ARKG or HELX?
Over the past year, ARKG had a volatility of 44.59%, while HELX experienced 23.97%.
Which ETF is bigger: ARKG or HELX?
As of October 27, 2026, ARKG holds $2.18 B in assets under management (AUM), while HELX manages $35.46 M.
What sectors do the ARKG and HELX ETFs invest in?
ARKG leans toward sectors like Healthcare. Meanwhile, HELX focuses on Healthcare.
What are the top holdings of the ARKG ETF and HELX ETF?
ARKG top holdings include 10X Genomics, Inc., Twist Bioscience Corp. and Tempus AI, Inc.. HELX holds in its top three: Guardant Health, Inc., Natera, Inc. and Krystal Biotech, Inc..
Which ETF is more diversified: ARKG or HELX?
ARKG holds 31 securities with 74.64% of its assets in the top 15. HELX has 66 securities and a top 15 weight of 60.55%.
Advertisement
Latest news about ARKG & HELX
The Weekly ETF Market Monitor (October 19-23, 2026)
October 26, 2026
ARKG
Biotech ETFs – Investing in Health Innovation
July 21, 2022
ARKG
Advertisement
Advertisement
